SCHEMBL455106

SCHEMBL455106

COc1ccccc1NC(=S)NN=C1Nc2ccccc2C1=O

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.47
SMN1; SMN2 Q16637 5/20 0.46
LMNA P02545 3/20 0.46
MAPT P10636 3/20 0.46
MEN1 O00255 2/20 0.46
NPC1 O15118 1/20 0.46
RRM1 P23921 1/20 0.46
RRM2 P31350 1/20 0.46
RAB9A P51151 1/20 0.46
RRM2B Q7LG56 1/20 0.46
GAA P10253 4/20 0.46
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 3/20 0.46
HPGD P15428 2/20 0.45
ALOX12 P18054 3/20 0.44
HKDC1 Q2TB90 1/20 0.44
HTT P42858 1/20 0.44
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31491968 0.84 KMT2A (0.47) KMT2ASMN1; SMN2LMNAMAPTMEN1
SCHEMBL456490 0.84 KDM4E (0.43) KMT2ASMN1; SMN2LMNAMAPTMEN1
SCHEMBL456608 0.82 CYP1A2 (0.49) KMT2ASMN1; SMN2LMNAMAPTMEN1
SCHEMBL2877739 0.78 MAPT (0.51) KMT2ASMN1; SMN2LMNAMAPTMEN1
SCHEMBL2877863 0.78 ALDH1A1 (0.46) KMT2ASMN1; SMN2LMNAMAPTMEN1
SCHEMBL457313 0.76 TDP1 (0.56) KMT2ASMN1; SMN2LMNAMAPTMEN1
SCHEMBL470025 0.75 GAA (0.49) KMT2ASMN1; SMN2LMNAMAPTMEN1
SCHEMBL455312 0.75 MAPT (0.42) KMT2ASMN1; SMN2LMNAMAPTMEN1
SCHEMBL455238 0.75 RAB9A (0.44) SMN1; SMN2LMNAMAPTNPC1RAB9A
SCHEMBL457421 0.75 LRRK2 (0.42) KMT2ASMN1; SMN2LMNAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012033601-A1 THIOSEMICARBAZONES WITH MDR1 - INVERSE ACTIVITY THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) 2012-03-15 WO disclosed
EP-2240175-A2 COMPOUNDS WITH MDR1-INVERSE ACTIVITY The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services (US) 2010-10-20 EP disclosed
WO-2009102433-A2 COMPOUNDS WITH MDR1-INVERSE ACTIVITY THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2009-08-20 WO disclosed